Pre-pandemic, more than half of hospitals nab above-average Leapfrog safety grades

Dive Brief: One-third of the nation’s hospitals received A grades for the quality of care they provide, according to the Leapfrog Group’s annual survey, which graded more than 2,700 acute care facilities nationwide. Another 24% received B grades, suggesting that the nation’s hospitals are generally performing well in terms of the quality and safety of… Read More »

Plexaderm Reviews 2021: Does It Work Or A Scam?

Plexaderm Reduce signs of aging Non-harming ingredients Positive customer reviews Variety of products Plexaderm Based in US Clinically proven ingredients High customer satisfaction Complementing products Medical Benefits Reduce the aging skin appearance  Thickens fine lines Eye bags and wrinkles remedy Deals with crow’s feet About The Brand Are you starting to experience the signs of… Read More »

Ultra-expensive medicine a desperate need for thousands of babies around the world

Imagine your child is dying. There’s a drug that promises hope, promises to stop your baby’s illness dead in its tracks. But this dream medicine is out of reach because it costs around $ 2 million, depending where you live. This is the story of many of parents of children with Spinal Muscular Atrophy (SMA), a rare motor neuron disease. Between one in 6,000… Read More »

AstraZeneca’s diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance

AstraZeneca’s diabetes med Farxiga stormed the heart failure market with a first-in-class approval last year—and in chronic kidney disease, it just left would-be rival Jardiance in the dust.  The FDA late Friday approved Farxiga, also known as dapagliflozin, to treat chronic kidney disease even in patients without diabetes. With that CKD approval in hand, Farxiga… Read More »